{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:36:33Z","timestamp":1790753793252,"version":"4.1.0"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Conventional treatment of chronic hepatitis B (CHB) is rarely curative due to the immunotolerant status of patients. RG7854 is an oral double prodrug of a toll-like receptor 7 (TLR7) agonist that is developed for the treatment of CHB. The therapeutic efficacy, host immune response, and safety of RG7854 were evaluated in the woodchuck model of CHB. Monotreatment with the two highest RG7854 doses and combination treatment with the highest RG7854 dose and entecavir (ETV) suppressed viral replication, led to loss of viral antigens, and induced seroconversion in responder woodchucks. Since viral suppression and high-titer antibodies persisted after treatment ended, this suggested that a sustained antiviral response (SVR) was induced by RG7854 in a subset of animals. The SVR rate, however, was comparable between both treatment regimens, suggesting that the addition of ETV did not enhance the therapeutic efficacy of RG7854 although it augmented the proliferation of blood cells in response to viral antigens and magnitude of antibody titers. The induction of interferon-stimulated genes in blood by RG7854\/ETV combination treatment demonstrated on-target activation of TLR7. Together with the virus-specific blood cell proliferation and the transient elevations in liver enzymes and inflammation, this suggested that cytokine-mediated non-cytolytic and T-cell mediated cytolytic mechanisms contributed to the SVR, in addition to the virus-neutralizing effects by antibody-producing plasma cells. Both RG7854 regimens were not associated with treatment-limiting adverse effects but accompanied by dose-dependent, transient neutropenia and thrombocytopenia. The study concluded that finite, oral RG7854 treatment can induce a SVR in woodchucks that is based on the retrieval of antiviral innate and adaptive immune responses. This supports future investigation of the TLR7 agonist as an immunotherapeutic approach for achieving functional cure in patients with CHB.<\/jats:p>","DOI":"10.3389\/fimmu.2022.884113","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T14:39:14Z","timestamp":1653316754000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Toll-Like Receptor 7 Agonist RG7854 Mediates Therapeutic Efficacy and Seroconversion in Woodchucks With Chronic Hepatitis B"],"prefix":"10.3389","volume":"13","author":[{"given":"Steffen","family":"Wildum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle E.","family":"Korolowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manasa","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lue","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changsuek","family":"Yon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"De Vera Mudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Regenass-Lechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xupeng","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta G.","family":"Murreddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaskar V.","family":"Kallakury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A. T.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Menne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,23]]},"reference":[{"key":"B1","unstructured":"Hepatitis B2021"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12749","article-title":"HBV and the Immune Response","author":"Ferrari","year":"2015","journal-title":"Liver Int"},{"key":"B3","doi-asserted-by":"publisher","first-page":"a021428","DOI":"10.1101\/cshperspect.a021428","article-title":"Immune Response in Hepatitis B Virus Infection","volume":"5","author":"Tan","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.08.019","article-title":"Spontaneous Seroclearance of Hepatitis B Surface Antigen and Risk of Hepatocellular Carcinoma","volume":"17","author":"Song","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.10.014","article-title":"HBsAg Seroclearance Further Reduces Hepatocellular Carcinoma Risk After Complete Viral Suppression With Nucleos(T)Ide Analogues","volume":"70","author":"Yip","year":"2019","journal-title":"J Hepatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92250-W","article-title":"Clinical Aspects of Hepatitis B Virus Infection","volume":"342","author":"Wright","year":"1993","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00224-3","article-title":"Lifelong Protection Against Hepatitis B: The Role of Vaccine Immunogenicity in Immune Memory","volume":"19","author":"Banatvala","year":"2000","journal-title":"Vaccine"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0037-0","article-title":"Therapeutic Strategies for Hepatitis B Virus Infection: Towards a Cure","volume":"18","author":"Fanning","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.9.4165-4173.2000","article-title":"Intrahepatic Induction of Alpha\/Beta Interferon Eliminates Viral RNA-Containing Capsids in Hepatitis B Virus Transgenic Mice","volume":"74","author":"Wieland","year":"2000","journal-title":"J Virol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/science.1243462","article-title":"Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA","volume":"343","author":"Lucifora","year":"2014","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006296","article-title":"Interferon-Inducible Ribonuclease ISG20 Inhibits Hepatitis B Virus Replication Through Directly Binding to the Epsilon Stem-Loop Structure of Viral RNA","volume":"13","author":"Liu","year":"2017","journal-title":"PloS Pathog"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI58847","article-title":"IFN-Alpha Inhibits HBV Transcription and Replication in Cell Culture and in Humanized Mice by Targeting the Epigenetic Regulation of the Nuclear cccDNA Minichromosome","volume":"122","author":"Belloni","year":"2012","journal-title":"J Clin Invest"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2019.04.002","article-title":"Understanding the Natural History of Hepatitis B Virus Infection and the New Definitions of Cure and the Endpoints of Clinical Trials","volume":"23","author":"Likhitsup","year":"2019","journal-title":"Clin Liver Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/v12030285","article-title":"The Interactions Between HBV and the Innate Immunity of Hepatocytes","volume":"12","author":"Megahed","year":"2020","journal-title":"Viruses"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3851\/IMP2542","article-title":"New Insights Into How HBV Manipulates the Innate Immune Response to Establish Acute and Persistent Infection","volume":"18","author":"Revill","year":"2013","journal-title":"Antivir Ther"},{"key":"B16","doi-asserted-by":"publisher","first-page":"935295","DOI":"10.1155\/2013\/935295","article-title":"Hepatitis B Surface Antigen Could Contribute to the Immunopathogenesis of Hepatitis B Virus Infection","volume":"2013","author":"Kondo","year":"2013","journal-title":"ISRN Gastroenterol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.jhep.2016.12.024","article-title":"Intrahepatic Innate Immune Response Pathways are Downregulated in Untreated Chronic Hepatitis B","volume":"66","author":"Lebosse","year":"2017","journal-title":"J Hepatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/v9050095","article-title":"Interplay Between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic Concepts","volume":"9","author":"Faure-Dupuy","year":"2017","journal-title":"Viruses"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0401771101","article-title":"Genomic Analysis of the Host Response to Hepatitis B Virus Infection","volume":"101","author":"Wieland","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21482","article-title":"Regulation of Toll-Like Receptor-2 Expression in Chronic Hepatitis B by the Precore Protein","volume":"45","author":"Visvanathan","year":"2007","journal-title":"Hepatology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201625","article-title":"Hepatitis B Virus Surface Antigen Selectively Inhibits TLR2 Ligand-Induced IL-12 Production in Monocytes\/Macrophages by Interfering With JNK Activation","volume":"190","author":"Wang","year":"2013","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026315","article-title":"Hepatitis B Virus Impairs TLR9 Expression and Function in Plasmacytoid Dendritic Cells","volume":"6","author":"Vincent","year":"2011","journal-title":"PloS One"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22751","article-title":"Hepatitis B Virus Suppresses Toll-Like Receptor-Mediated Innate Immune Responses in Murine Parenchymal and Nonparenchymal Liver Cells","volume":"49","author":"Wu","year":"2009","journal-title":"Hepatology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903874","article-title":"The Hepatitis B Virus X Protein Disrupts Innate Immunity by Downregulating Mitochondrial Antiviral Signaling Protein","volume":"185","author":"Wei","year":"2010","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20366","article-title":"Functional Impairment of Myeloid and Plasmacytoid Dendritic Cells of Patients With Chronic Hepatitis B","volume":"40","author":"van der Molen","year":"2004","journal-title":"Hepatology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2008.02896.x","article-title":"Hepatitis B Virus Surface Antigen Impairs Myeloid Dendritic Cell Function: A Possible Immune Escape Mechanism of Hepatitis B Virus","volume":"126","author":"Op den Brouw","year":"2009","journal-title":"Immunology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-004-6249-y","article-title":"Decreased Frequency and Function of Circulating Plasmocytoid Dendritic Cells (pDC) in Hepatitis B Virus Infected Humans","volume":"24","author":"Duan","year":"2004","journal-title":"J Clin Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2014.95","article-title":"Dissecting the Dendritic Cell Controversy in Chronic Hepatitis B Virus Infection","volume":"12","author":"Gehring","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1053\/j.gastro.2015.11.050","article-title":"Hepatitis B Virus\u2013Specific and Global T-Cell Dysfunction in Chronic Hepatitis B","volume":"150","author":"Park","year":"2016","journal-title":"Gastroenterology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI121960","article-title":"Circulating and Intrahepatic Antiviral B Cells are Defective in Hepatitis B","volume":"128","author":"Burton","year":"2018","journal-title":"J Clin Invest"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.04.019","article-title":"Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus Infection","volume":"159","author":"Le Bert","year":"2020","journal-title":"Gastroenterology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jhep.2019.07.015","article-title":"Comparative Characterization of B Cells Specific for HBV Nucleocapsid and Envelope Proteins in Patients With Chronic Hepatitis B","volume":"72","author":"Le Bert","year":"2020","journal-title":"J Hepatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.01.034","article-title":"Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver","volume":"154","author":"Suslov","year":"2018","journal-title":"Gastroenterology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1053\/j.gastro.2018.01.044","article-title":"HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon","volume":"154","author":"Mutz","year":"2018","journal-title":"Gastroenterology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coviro.2018.01.008","article-title":"Modulators of Innate Immunity as Novel Therapeutics for Treatment of Chronic Hepatitis B","volume":"30","author":"Suslov","year":"2018","journal-title":"Curr Opin Virol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03127","article-title":"Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection","volume":"10","author":"Meng","year":"2019","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.immuni.2020.03.017","article-title":"Distinct and Orchestrated Functions of RNA Sensors in Innate Immunity","volume":"53","author":"Liu","year":"2020","journal-title":"Immunity"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.4MR0316-108R","article-title":"Emerging Roles of the Processing of Nucleic Acids and Toll-Like Receptors in Innate Immune Responses to Nucleic Acids","volume":"101","author":"Miyake","year":"2017","journal-title":"J Leukoc Biol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2016.06.026","article-title":"The Link Between TLR7 Signaling and Hepatitis B Virus Infection","volume":"158","author":"Sepehri","year":"2016","journal-title":"Life Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1053\/j.gastro.2013.02.003","article-title":"GS-9620, an Oral Agonist of Toll-Like Receptor-7, Induces Prolonged Suppression of Hepatitis B Virus in Chronically Infected Chimpanzees","volume":"144","author":"Lanford","year":"2013","journal-title":"Gastroenterology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.12.026","article-title":"Sustained Efficacy and Seroconversion With the Toll-Like Receptor 7 Agonist GS-9620 in the Woodchuck Model of Chronic Hepatitis B","volume":"62","author":"Menne","year":"2015","journal-title":"J Hepatol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/hep.31255","article-title":"Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B","volume":"73","author":"Daffis","year":"2021","journal-title":"Hepatology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.037","article-title":"The Oral Toll-Like Receptor-7 Agonist GS-9620 in Patients With Chronic Hepatitis B Virus Infection","volume":"63","author":"Gane","year":"2015","journal-title":"J Hepatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.10.027","article-title":"Safety, Efficacy and Pharmacodynamics of Vesatolimod (GS-9620) in Virally Suppressed Patients With Chronic Hepatitis B","volume":"68","author":"Janssen","year":"2018","journal-title":"J Hepatol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1053\/j.gastro.2018.01.030","article-title":"TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues","volume":"154","author":"Boni","year":"2018","journal-title":"Gastroenterology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1397","article-title":"Liver-Targeted Toll-Like Receptor 7 Agonist Combined With Entecavir Promotes a Functional Cure in the Woodchuck Model of Hepatitis B Virus","volume":"3","author":"Korolowizc","year":"2019","journal-title":"Hepatol Commun"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.75.9.4533","article-title":"A Virus Similar to Human Hepatitis B Virus Associated With Hepatitis and Hepatoma in Woodchucks","volume":"75","author":"Summers","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i1.104","article-title":"The Woodchuck as an Animal Model for Pathogenesis and Therapy of Chronic Hepatitis B Virus Infection","volume":"13","author":"Menne","year":"2007","journal-title":"World J Gastroenterol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.09.043","article-title":"Hepatocellular Carcinoma in the Woodchuck Model of Hepatitis B Virus Infection","volume":"127","author":"Tennant","year":"2004","journal-title":"Gastroenterology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-014-0379-5","article-title":"Therapeutic Vaccination and Immunomodulation in the Treatment of Chronic Hepatitis B: Preclinical Studies in the Woodchuck","volume":"204","author":"Kosinska","year":"2015","journal-title":"Med Microbiol Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00853","article-title":"Diverse Virus and Host-Dependent Mechanisms Influence the Systemic and Intrahepatic Immune Responses in the Woodchuck Model of Hepatitis B","volume":"11","author":"Michalak","year":"2020","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v13.i6.509","article-title":"Application of the Woodchuck Animal Model for the Treatment of Hepatitis B Virus-Induced Liver Cancer","volume":"13","author":"Suresh","year":"2021","journal-title":"World J Gastrointest Oncol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1053\/he.2000.5982","article-title":"Treatment of Chronic Woodchuck Hepatitis Virus Infection in the Eastern Woodchuck (Marmota Monax) With Nucleoside Analogues is Predictive of Therapy for Chronic Hepatitis B Virus Infection in Humans","volume":"31","author":"Korba","year":"2000","journal-title":"Hepatology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1086\/324003","article-title":"Long-Term Entecavir Treatment Results in Sustained Antiviral Efficacy and Prolonged Life Span in the Woodchuck Model of Chronic Hepatitis Infection","volume":"184","author":"Colonno","year":"2001","journal-title":"J Infect Dis"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161313","article-title":"Antiviral Efficacy and Host Innate Immunity Associated With SB 9200 Treatment in the Woodchuck Model of Chronic Hepatitis B","volume":"11","author":"Korolowicz","year":"2016","journal-title":"PloS One"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12791","article-title":"A Single and Multiple Ascending Dose Study of Toll-Like Receptor 7 Agonist (RO7020531) in Chinese Healthy Volunteers","volume":"13","author":"Luk","year":"2020","journal-title":"Clin Transl Sci"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(18)31878-6","article-title":"Preclinical Mechanistic and Efficacy Evaluation of a Novel Small Molecule TLR7 Agonist RO7020531 for the Treatment of Chronic Hepatitis B","volume":"68","author":"Dai","year":"2018","journal-title":"J Hepatol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00654-08","article-title":"Antiviral Effects of Lamivudine, Emtricitabine, Adefovir Dipivoxil, and Tenofovir Disoproxil Fumarate Administered Orally Alone and in Combination to Woodchucks With Chronic Woodchuck Hepatitis Virus Infection","volume":"52","author":"Menne","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/v13040648","article-title":"Treatment With the Immunomodulator AIC649 in Combination With Entecavir Produces Antiviral Efficacy in the Woodchuck Model of Chronic Hepatitis B","volume":"13","author":"Korolowicz","year":"2021","journal-title":"Viruses"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1089\/vim.1993.6.161","article-title":"New Enzyme Immunoassays for the Serologic Detection of Woodchuck Hepatitis Virus Infection","volume":"6","author":"Cote","year":"1993","journal-title":"Viral Immunol"},{"key":"B61","doi-asserted-by":"crossref","DOI":"10.1016\/B978-012263951-7\/50011-9","article-title":"Woodchucks as Laboratory Animals","volume-title":"Laboratory Animal Medicine","author":"Bellezza","year":"2002"},{"key":"B62","article-title":"Laboratory Assessment of Hepatic Injury in the Woodchuck (Marmota Monax)","volume":"35","author":"Hornbuckle","year":"1985","journal-title":"Lab Anim Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.20899","article-title":"Antiviral Activity of Clevudine [L-FMAU, (1-(2-Fluoro-5-Methyl-Beta, L-Arabinofuranosyl) Uracil)] Against Woodchuck Hepatitis Virus Replication and Gene Expression in Chronically Infected Woodchucks (Marmota Monax)","volume":"33","author":"Peek","year":"2001","journal-title":"Hepatology"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280124","article-title":"Antiviral Activity and Toxicity of Fialuridine in the Woodchuck Model of Hepatitis B Virus Infection","volume":"28","author":"Tennant","year":"1998","journal-title":"Hepatology"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00691-07","article-title":"Chemoimmunotherapy of Chronic Hepatitis B Virus Infection in the Woodchuck Model Overcomes Immunologic Tolerance and Restores T-Cell Responses to Pre-S and S Regions of the Viral Envelope Protein","volume":"81","author":"Menne","year":"2007","journal-title":"J Virol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008248","article-title":"Innate and Adaptive Immunity Associated With Resolution of Acute Woodchuck Hepatitis Virus Infection in Adult Woodchucks","volume":"15","author":"Suresh","year":"2019","journal-title":"PloS Pathog"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1502","article-title":"Efficacy of an Inhibitor of Hepatitis B Virus Expression in Combination With Entecavir and Interferon-Alpha in Woodchucks Chronically Infected With Woodchuck Hepatitis Virus","volume":"4","author":"Menne","year":"2020","journal-title":"Hepatol Commun"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(18)30253-8","article-title":"Combination Treatment of a TLR7 Agonist RO7020531and a Capsid Assembly Modulator RO7049389 Achieved Sustainable Viral Loadsuppression and HBsAg Loss in an AAV-HBV Mouse Model","volume":"68","author":"Dai","year":"2018","journal-title":"J Hepatol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.coviro.2021.04.003","article-title":"Innate Immunity and HBV Persistence","volume":"49","author":"Chiale","year":"2021","journal-title":"Curr Opin Virol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13716","article-title":"ALT Flares During Nucleotide Analogue Therapy are Associated With HBsAg Loss in Genotype A HBeAg-Positive Chronic Hepatitis B","volume":"38","author":"Wong","year":"2018","journal-title":"Liver Int"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1420","article-title":"Fine-Tuning TLR-7-Based Therapy for Functional HBV Cure","volume":"3","author":"Bertoletti","year":"2019","journal-title":"Hepatol Commun"},{"key":"B72","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1053\/j.gastro.2012.07.014","article-title":"Restored Function of HBV-Specific T Cells After Long-Term Effective Therapy With Nucleos(T)Ide Analogues","volume":"143","author":"Boni","year":"2012","journal-title":"Gastroenterology"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1172\/JCI92812","article-title":"Hepatitis B Virus-Specific T Cells Associate With Viral Control Upon Nucleos(T)Ide-Analogue Therapy Discontinuation","volume":"128","author":"Rivino","year":"2018","journal-title":"J Clin Invest"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.06.009","article-title":"Preserved T-Cell Function in Children and Young Adults With Immune-Tolerant Chronic Hepatitis B","volume":"143","author":"Kennedy","year":"2012","journal-title":"Gastroenterology"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2015.25","article-title":"Reversal of B-Cell Hyperactivation and Functional Impairment is Associated With HBsAg Seroconversion in Chronic Hepatitis B Patients","volume":"12","author":"Xu","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.7.4043","article-title":"Plasmacytoid Dendritic Cells Control TLR7 Sensitivity of Naive B Cells via Type I IFN","volume":"174","author":"Bekeredjian-Ding","year":"2005","journal-title":"J Immunol"},{"key":"B77","unstructured":"ClinicalTrials.gov. NCT042257152022"},{"key":"B78","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1124\/jpet.113.207878","article-title":"Pharmacokinetic and Pharmacodynamic Properties of GS-9620, a Novel Toll-Like Receptor 7 Agonist, Demonstrate Interferon-Stimulated Gene Induction Without Detectable Serum Interferon at Low Oral Doses","volume":"348","author":"Fosdick","year":"2014","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.884113\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T14:39:20Z","timestamp":1653316760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.884113\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,23]]},"references-count":78,"alternative-id":["10.3389\/fimmu.2022.884113"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.884113","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,23]]},"article-number":"884113"}}